Accès ouvert · CC BY

Distinguishing caffeine expectancy from pharmacological effects: a comparative review of experimental designs with future directions

Article scientifique 2026 Sciences de la santé Anglais

Résumé

Caffeine (CAF) is among the most widely consumed bioactive substances and is recognized for its ergogenic benefits. Yet, separating its expectancy-driven effects from pharmacological effects remains challenging. This review compares the randomized double-blind placebo-controlled crossover, deceptive placebo-balanced, and double-deceptive placebo-balanced crossover designs commonly used in CAF studies. While the double-blind crossover design effectively controls individual variability, it cannot directly measure expectancy. In contrast, placebo-balanced crossover designs incorporating deception provide the most comprehensive framework when the aim is to separate pharmacological and expectancy-related effects, allowing a more precise interpretation of caffeine's mechanisms. Differences in studies designs may partially explain inconsistencies in the literature, as expectancy-related components are not equally controlled across experimental approaches.

Citer ce document

Delleli, S., Díaz‐Lara, J., & Chtourou, H. (2026). Distinguishing caffeine expectancy from pharmacological effects: a comparative review of experimental designs with future directions. Frontiers in Physiology. https://doi.org/10.3389/fphys.2026.1865993

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 01/10/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 15

Téléchargements (hors robots) : 0

Méthode de comptage